A randomized, multicenter, open label, comparative study to evaluate the immunogenicity and reactogenicity of a new fully liquid pentavalent DTwP-Hib-IPV vaccine (EasyfourPol, Panacea Biotec Ltd.) with tetravalent DTwP/Hib vaccine (TetrAct-Hib), co-administered with Imovax Polio (Salk Based Inactivated Polio Vaccine) of sanofi pasteur India Pvt. Ltd. in Healthy Infants.
Phase of Trial: Phase II/III
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Hib-DTP-poliovirus vaccine (Primary) ; Hib-DTP vaccine; Poliovirus vaccine inactivated
- Indications Diphtheria; Haemophilus infections; Pertussis; Poliomyelitis; Tetanus
- Focus Pharmacodynamics
- Sponsors Panacea Biotec
- 04 Mar 2011 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India.
- 24 Feb 2011 New trial record